INSIGHTS ON CLINICAL TRIAL PARTNERING

CLINICAL TRIAL PARTNERING SOLUTIONS

  • Streamline study activation and increase efficiencies with the partner trusted by tens of thousands of sites, institutions, academic medical centers, cancer centers, and health systems worldwide.

  • Accelerate your biotech trials in Australia—cut costs by up to 60%, enroll patients in as little as 4–6 weeks, and generate FDA- and EMA-accepted data with no IND required.

  • The quality of your drug safety team is of the highest importance. That’s why you need an experienced and committed partner who commands the regulatory landscape with confidence. Our global and scalable safety solutions are designed to be efficient, affordable, and fully compliant, giving you flexibility and peace of mind in a complex clinical environment.

  • Navigating drug safety in the era of innovation-driven medicine

    The focus on drug safety and pharmacovigilance has never been more intense. Patient safety remains paramount throughout a product's lifecycle, even as sponsors and marketing authorization holders (MAHs) face increasing complexity in managing safety data. This complexity stems from huge volumes of data generated from scores of diverse sources, much of it rapidly expanding unstructured data. Innovation-driven medicine is a key factor. These dynamics are reshaping the landscape of drug safety, presenting both challenges and opportunities for innovation in pharmacovigilance practices.

  • The success of a biotech drug development program often depends on the relationship it forms with its Clinical Research Organization (CRO) partner.

    Avance Clinical, a global CRO with more than 3 decades of experience, has an impressive track record in the US with over 200 US studies including 140 in oncology.